Please login to the form below

Not currently logged in
Email:
Password:

Partnership to reach Chinese patients

Ireland-based ICON and China's Tigermed Consulting have signed an alliance agreement to improve access to Chinese patients

ICON, headquartered in Ireland, and China's Tigermed Consulting have signed an alliance agreement to improve access to Chinese patients.

ICON provides outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting provides clinical drug development services in China.

Through the agreement, ICON and Tigermed will collaborate to offer pharmaceutical and biotechnology clients better access to Chinese patients, combining the global reach and experience of ICON with Tigermed's knowledge of the Chinese drug development situation and geographic coverage in China.

"Tigermed has a substantial clinical operations presence on the Chinese mainland and this experience gives it the ability to provide wide-ranging support for clinical drug development in China," said Dr John Hubbard, group president, global clinical research services at ICON. "TigerMed's strength in China complements ICON's strong regional presence in Asia Pacific and makes it the ideal partner for ICON as we continue to drive the rapid and effective development of our client's global drug development portfolios."

"We are extremely pleased to have signed this agreement with ICON," commented Xiaoping Ye, chairman and CEO of Tigermed.

"Not only is ICON recognised as a truly global provider of quality clinical services, its culture and core values built around people, performance and client focus fit well with those of Tigermed. This alliance enhances our regional and global capabilities and will enable both ICON and Tigermed to expand the range of clinical research services we can offer to clients in China and around the globe."

With headquarters in Shanghai, Tigermed currently operates from 21 offices in China and has over 300 clinical development staff there. ICON operates from 69 locations in 39 countries and has approximately 7,300 employees.

7th April 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics